Baroda Chemist Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 09-12-2024
- Paid Up Capital ₹ 0.50 M
as on 09-12-2024
- Company Age 74 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 3.70 M
as on 09-12-2024
- Revenue 262.80%
(FY 2022)
- Profit 237.36%
(FY 2022)
- Ebitda 266.21%
(FY 2022)
- Net Worth 38.58%
(FY 2022)
- Total Assets -42.14%
(FY 2022)
About Baroda Chemist
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.50 M.
The company currently has active open charges totaling ₹3.70 M.
Dakshay Thakkar, Dhrutika Thakkar, and Krishneel Thakkar serve as directors at the Company.
- CIN/LLPIN
U24231GJ1950PTC000524
- Company No.
000524
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
06 Nov 1950
- Date of AGM
25 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Vadodara, Gujarat, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Baroda Chemist?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Dakshay Thakkar  | Director | 01-Apr-1989 | Current |
| Dhrutika Thakkar | Director | 17-Aug-2015 | Current |
| Krishneel Thakkar | Director | 26-Nov-2019 | Current |
Financial Performance of Baroda Chemist.
Baroda Chemist Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 262.8% increase. The company also saw a substantial improvement in profitability, with a 237.36% increase in profit. The company's net worth Soared by an impressive increase of 38.58%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Baroda Chemist?
In 2022, Baroda Chemist had a promoter holding of 66.80% and a public holding of 33.20%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Khlorophylls Biotech Private LimitedActive 14 years 4 monthsDakshay Thakkar and Dhrutika Thakkar are mutual person
Luminary Foundation Of Entrepreneurship DevelopmentActive 7 years 5 monthsDakshay Thakkar is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Bank Of Baroda Creation Date: 15 Sep 1999 | ₹1.25 M | Open |
Bank Of Baroda Creation Date: 15 Sep 1989 | ₹2.45 M | Open |
How Many Employees Work at Baroda Chemist?
Unlock and access historical data on people associated with Baroda Chemist, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Baroda Chemist, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Baroda Chemist's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
